Clinical trial
Airflow Limitation in Cardiac Diseases in Europe
NCT01485159 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Airflow Limitation in Cardiac Diseases in Europe
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- June 30, 2012
- Enrollment
- 3,000 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.